ENVUE MEDICAL INC NEW
FEED
FEED was delisted on the 15th of September, 2026.
4 hedge funds and large institutions have $18.1K invested in ENVUE MEDICAL INC NEW in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 0 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
33% more funds holding
Funds holding: 3 → 4 (+1)
0.16% less ownership
Funds ownership: 2.61% → 2.45% (-0.16%)
73% less capital invested
Capital invested by funds: $67.5K → $18.1K (-$49.4K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$25.4K |
| 2 |
Citigroup
New York
|
+$7.51K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.93K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$37.2K |
FEED Hedge Fund Activity: Q2 2025 in Review
4 of the 7,614 institutional investors tracked by Wall St. Rank reported a position in ENVUE MEDICAL INC NEW (FEED) for Q2 2025, worth a combined $18.1K — down 73% from $67.5K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new FEED positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 1 trimmed.
The largest buyer was UBS Group, adding an estimated $25.4K. The largest seller was Morgan Stanley, cutting an estimated $37.2K.
- 4 institutional investors held ENVUE MEDICAL INC NEW (FEED) as of Q2 2025, up from 3 in Q1 2025.
- Funds reported $18.1K of ENVUE MEDICAL INC NEW stock for Q2 2025, down 73% quarter-over-quarter.
- 1 fund opened new ENVUE MEDICAL INC NEW positions in Q2 2025 and 0 closed out, a net change of +1 holder.
- The largest ENVUE MEDICAL INC NEW buyer in Q2 2025 was UBS Group, an estimated $25.4K added.
- The largest ENVUE MEDICAL INC NEW seller in Q2 2025 was Morgan Stanley, an estimated $37.2K sold.
Based on aggregated 13F filings for Q2 2025.